DTx Commercialization and Reimbursement

 View Only

About this Group

This group works through expanding and standardizing the commercial pathways for reimbursement of DTx products. The group is working to ensure the successful adoption of the Digital Mental Health Treatment (DMHT) codes, building formulary and medical policy standards, and dissecting successful launch strategies. Also monitors and informs ATA Action policy and legislative efforts.

SIG Leader
SIG Leader

Upcoming Events


Latest Discussions

Announcements

  • Welcome!

    Welcome to the Digital Therapeutics Commercialization and Reimbursement SIG! We meet bi-monthly on the second Tuesday of the month at 12p Eastern Time.

    See our upcoming meetings and RSVP to a meeting to receive a calendar hold in your email.

Latest Library Entries